NRF2
Showing 1 - 25 of 221
Aging Problems Trial in Flagstaff (Sulforaphane, Placebo capsules)
Recruiting
- Aging Problems
- Sulforaphane
- Placebo capsules
-
Flagstaff, ArizonaNorthern Arizona University
Sep 26, 2022
Exposure to Polluted Air Trial in Yangzhou
Active, not recruiting
- Exposure to Polluted Air
-
Yangzhou, Jiangsu, ChinaWenjing Zhao
Feb 21, 2023
Head Neck Cancer, Head Neck Cancer Trial in Saint Louis (Pyrimethamine)
Not yet recruiting
- Head and Neck Cancer
- Cancer of the Head and Neck
-
Saint Louis, MissouriWashington University School of Medicine
Jan 4, 2023
PM2.5 Exposure and Ferroptosis in Seizures Patients
Active, not recruiting
- Exposure to Polluted Air
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of JiangNan University, Department of Pediat
Mar 5, 2023
Effects of Lead Exposure on Ferroptosis Pathway
Recruiting
- Lead Poisoning
- Neurotoxicity
- Lead exposure
-
Yangzhou, Jiangsu, ChinaWenjing Zhao
Jul 19, 2023
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 15, 2022
Diastolic Dysfunction, Systolic Dysfunction, Diastolic Heart Failure Trial in Lubbock (Sulforaphane)
Recruiting
- Diastolic Dysfunction
- +2 more
-
Lubbock, TexasTexas Tech University Health Sciences Center (TTUHSC)
Sep 2, 2022
lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome
Enrolling by invitation
- Acute Respiratory Distress Syndrome
- Inflammation
- no intervention
-
Beijing, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing An
Jun 16, 2021
Chronic Kidney Disease, Hypertension, Diabetes Trial in Rio de Janeiro (physical exercises)
Completed
- Chronic Kidney Disease
- +2 more
- physical exercises
-
Rio de Janeiro, RJ, BrazilDenise Mafra
Oct 18, 2020
NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (Liquid Biopsy
Active, not recruiting
- Non-Small Cell Lung Cancer
- +5 more
- Liquid Biopsy NGS Test
-
Daphne, Alabama
- +62 more
Nov 5, 2021
Osteoarthritis, Knee, Muscle Weakness, Pain, Joint Trial in Fort Collins (PB125, Placebo)
Recruiting
- Osteoarthritis, Knee
- +2 more
- PB125
- Placebo
-
Fort Collins, ColoradoColorado State University
Nov 16, 2020
Comparative Bioavailability Trial in Erfurt (GLA-015, DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml")
Completed
- Comparative Bioavailability
- GLA-015
- DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml"
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH Clinical Pharmacology Unit
Jul 12, 2021
Physical Fitness Trial in Makassar (Multistage Fitness Test)
Completed
- Physical Fitness
- Multistage Fitness Test
-
Makassar, South Sulawesi, IndonesiaMakassar Center for Health Training
Apr 28, 2020
NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (drug,
Terminated
- Non-Small Cell Lung Cancer
- +5 more
- Telaglenastat
- +7 more
-
Birmingham, Alabama
- +101 more
Mar 8, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Pharmacodynamic Study
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +30 more
Sep 1, 2022
Inflammatory Markers in MI Patients
Not yet recruiting
- Myocardial Infarction
- Percutaneous coronary intervention
-
Bolu, Merkez, TurkeyBolu Abant Izzet University faculty of Medicine Department of Em
Jul 27, 2022
Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)
Recruiting
- Anthracycline Related Cardiotoxicity in Breast Cancer
- sulforaphane
- Placebo Oral Tablet
-
Lubbock, TexasTexas Tech University Health Sciences Center
Jul 18, 2022
Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) Trial in Salt Lake City (PB125, Placebo,
Not yet recruiting
- Peripheral Artery Disease (D058729)
- +2 more
- PB125
- +2 more
-
Salt Lake City, Utah
- +1 more
Dec 8, 2022
Chronic Kidney Disease Trial in Rio de Janeiro (L-sulforaphane 1%, Placebo Group)
Recruiting
- Chronic Kidney Disease
- L-sulforaphane 1%
- Placebo Group
-
Rio de Janeiro, BrazilDenise Mafra
Jan 4, 2022
Metabolic Disturbance Trial in Stockholm (Isothiocyanate rich sprouts, Placebo Juice)
Active, not recruiting
- Metabolic Disturbance
- Isothiocyanate rich sprouts
- Placebo Juice
-
Stockholm, SwedenSwedish School of Sports and Health Sciences
Dec 5, 2022
Coronavirus Trial in South Africa (ChAdOx1 nCoV-19, Normal saline 0.9%)
Unknown status
- Coronavirus
- ChAdOx1 nCoV-19
- Normal saline 0.9%
-
Johannesburg, Gauteng, South Africa
- +6 more
Nov 23, 2020
Chronic Kidney Diseases, Inflammation Trial in Rio de Janeiro (Microcapsules with turmeric and propolis)
Not yet recruiting
- Chronic Kidney Diseases
- Inflammation
- Microcapsules with turmeric and propolis
-
Rio de Janeiro, RJ, BrazilDenise Mafra
Jan 4, 2022
Diabetes, Non-Insulin-Dependent Trial (sulforaphane, Placebo)
Completed
- Diabetes Mellitus, Non-Insulin-Dependent
- sulforaphane
- Placebo
- (no location specified)
Jan 14, 2022